Dr. Taplin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
D1230
Boston, MA 02115Phone+1 617-582-7221Fax+1 617-632-2165
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
- UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1990
- University of Massachusetts Medical SchoolClass of 1986
Certifications & Licensure
- MA State Medical License 1987 - 2025
- NH State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy Start of enrollment: 1997 Jan 01
- A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer Start of enrollment: 2004 Jan 01
- Mifepristone (RU-486) in Androgen Independent Prostate Cancer Start of enrollment: 2005 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 777 citationsGenomic correlates of clinical outcome in advanced prostate cancer.Wassim Abida, Joanna Cyrta, Glenn Heller, Davide Prandi, Joshua Armenia
Proceedings of the National Academy of Sciences of the United States of America. 2019-06-04 - 807 citationsIntegrative clinical genomics of advanced prostate cancer.Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro
Cell. 2015-05-21 - 543 citationsThe long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A. Wankowicz, David Liu, Jianjiong Gao, Ritika Kundra
Nature Genetics. 2018-04-02
Lectures
- PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to ...2019 ASCO Annual Meeting - 6/1/2019
- Optimizing Androgen Receptor Targeting Strategies Perspective2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Other
- Clinical presentation and diagnosis of prostate cancerTaplin M, Smith JA, Kantoff PW
http://www.uptodate.com/contents/clinical-presentation-and-diagnosis-of-prostate-cancer
UpToDate, Wolters Kluwer Health - 2013-02-05 - Initial staging and evaluation of men with newly diagnosed prostate cancerTaplin M, Smith JA, Kantoff PW
http://www.uptodate.com/contents/initial-staging-and-evaluation-of-men-with-newly-diagnosed-prostate
UpToDate, Wolters Kluwer Health - 2013-02-05 - Testicular sex cord stromal tumorsTaplin M
http://www.uptodate.com/contents/testicular-sex-cord-stromal-tumors
UpToDate, Wolters Kluwer Health - 2012-04-18
Authored Content
- Clinical and Genomic Characterization of Low–Prostate-Specific Antigen, High-Grade Prostate CancerFebruary 2018
Press Mentions
- Neoadjuvant NHAs Followed by Surgery Can Improve Key Outcomes in High-Risk Prostate Cancer PatientsSeptember 12th, 2022
- The Prostate Cancer Foundation Announces First Ever Pcf-Pfizer Global Health Equity Challenge Award WinnersApril 29th, 2022
- Rana R. McKay, MD: Developing Clinical Trials to Answer Questions Raised in PracticeApril 20th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: